Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Fidelity Emerging Markets Limited (LON:FEML) has announced its monthly factsheet for September 2023. Emerging markets declined in September and marginally underperformed developed markets. US Treasury yields reached near multi-year highs..
BlackRock Frontiers Investment Trust plc (LON:BRFI) has announced its latest portfolio update. You can discover more about the BlackRock Frontiers Investment Trust at blackrock.com/uk/brfi All information is at 30 September..
BlackRock World Mining Trust plc (LON:BRWM) has announced its latest portfolio update. For more information on the Blackrock World Mining Trust and how to access the opportunities presented by mining,..
Hunting PLC (LON:HTG), the global precision engineering group, has announced a further major subsea order and also issues a Q3 2023 trading update. Highlights · $59 million order for titanium stress..
Senior plc (LON:SNR), an international manufacturer of high technology components and systems, has announced that Senior Flexonics Crumlin has secured a production order for Battery Cooling Plates with Valmet Automotive..
Darktrace plc (LON:DARK), a global leader in cyber security AI, has unveiled a new Darktrace/Cloud™ solution based on its unique Self-Learning AI. The new solution provides comprehensive visibility of cloud..
Unilever plc (LON:ULVR) has announced Fernando Fernandez as its new Chief Financial Officer after a thorough internal and external search process. Fernando, currently President of Unilever’s Beauty & Wellbeing Business..
Standard Chartered PLC (LON:STAN) has announced its results for the third quarter ended 30 September 2023. All figures are presented on an underlying basis and comparisons are made to 2022..
GSK plc (LON/NYSE: GSK) has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders announced that the National Medical Products..
Wildcat Petroleum plc (LON:WCAT) has announced that the Chairman Mr. Mandhir Singh on 25 October 2023 purchased 26,300,000 Ordinary Shares (for his SIPP i.e Self-Invested Personal Pension account and ISA..
R&Q Insurance Holdings Ltd (LON:RQIH), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, has announced that it has signed a Loss Portfolio Transfer..
Poolbeg Pharma plc (LON:POLB) a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, has announced that its Scientific Advisory Board (‘SAB’) has endorsed the influenza drug targets..
Focusing on the world’s smaller markets brings its challenges, but they offer rare and idiosyncratic opportunities says Emily Fletcher, manager of the BlackRock Frontiers Investment Trust plc (LON:BRFI). Capital at..
The US’s vast climate change legislation programme is a year old. The team managing the BlackRock Sustainable American Income Trust plc (LON:BRSA) says the Act is driving innovation in new..
Nanoco Group Plc (LON:NANO), a pioneering figure in the world of nanotechnology, has announced impressive results for its year ending 31 July 2023. Reporting robust revenue growth and a notably..
VinaCapital Vietnam Opportunity Fund Limited (LON:VOF) has announced the appointment of Barclays Bank PLC as joint corporate broker alongside Deutsche Numis, its existing corporate broker, with effect from 26 October..
QinetiQ Group plc (LON:QQ) is today hosting a seminar where we will outline our overall strategy and drivers of our sustainable growth. 1. UK Intelligence – a high growth £400m..
Halma plc (LON:HLMA), the global group of life-saving technology companies, has announced that it has completed two bolt-on acquisitions for an aggregate maximum total consideration of approximately £46.5m. In the..
Reckitt Benckiser Group PLC (LON:RKT) has announced its Q3 trading statement. HYGIENE AND HEALTH STRONG GROWTH. NUTRITION REBASING Q3 2023 YTD 2023 Net revenue £m LFL1 Reported £m LFL1 Reported..
GSK plc (LON/NYSE: GSK) has announced positive preliminary results from its phase III trial [https://clinicaltrials.gov/study/NCT05590403] evaluating the immune response and safety of Arexvy (respiratory syncytial virus vaccine, adjuvanted) in adults..
